Picture of Humanigen logo

HGENQ — Humanigen News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Humanigen Inc expected to post a loss of 18 cents a share - Earnings Preview

* Humanigen Inc  HGEN.OQ   HGEN.O  is expected to show a
fall in
quarterly revenue when it reports  results on November 10
(estimated). 
    * The Short Hills New Jersey-based  company is expected to
report 
a 49.8% decrease in revenue to $520 thousand from $1.04 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Humanigen Inc is
for a
loss of 18 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Humanigen
Inc is
$2​, above​ its last closing price of $0.14. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.31       -0.30      -0.43     Missed  -45.4
 Mar. 31 2022  -0.47       -0.46      -0.32     Beat    30.8
 Dec. 31 2021  -0.68       -0.65      -0.53     Beat    18​
 Sep. 30 2021  -1.01       -0.98      -1.12     Missed  -13.8
 ​​Jun.        -0.83       -0.86      -1.20     Missed  -39.3
 30 2021                                                
 Mar. 31 2021  -0.71       -0.64      -1.25     Missed  -95.3​
 Dec. 31 2020  -0.68       -0.67      -0.63     Beat    6.3
 Sep. 30 2020  -0.57       -0.57      -0.71     Missed  -25.3
 This summary was machine generated November 9 at 03:03 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Humanigen

See all news